4 days Johnson & Johnson: Wait For More Clarity (Rating Downgrade) Seeking Alpha Johnson & Johnson: Wait For More Clarity (Rating Downgrade). Johnson & Johnson (JNJ)
5 hours Legend Biotech’s J&J-Partnered Drug Cut The Risk Of Death By 45% In Multiple MyelomaInvestor's Business Daily
1 day Is Johnson & Johnson (JNJ) the Best Stock To Buy Right Now According To Billionaire Cliff Asness?Insider Monkey
2 days Johnson & Johnson (JNJ): A Good Undervalued Blue Chip Stock to Buy According to AnalystsInsider Monkey
1 week Johnson & Johnson (JNJ) Faces Legal Challenges While Advancing MedTech Innovations for GrowthInsider Monkey
2 weeks Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?Investor's Business Daily
2 weeks Is Johnson & Johnson (JNJ) the Best Blue Chip Stock To Invest In According to Short Sellers?Insider Monkey
3 weeks Johnson & Johnson (JNJ) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)Seeking Alpha
1 month Is Johnson & Johnson (JNJ) The Best Dividend Paying Stock To Buy According to Quant Hedge Fund AQR?Insider Monkey
1 month Johnson & Johnson (JNJ): A Cheap Pharmaceutical Stock to Buy According to Short SellersInsider Monkey
1 month Is Johnson & Johnson (JNJ) The Best Among The S&P 500 Dividend Aristocrats According to Hedge Funds?Insider Monkey
2 months J&J has enough support from claimants for $6.5-billion talc settlement, Bloomberg reportsInvesting.com
2 months J&J has enough support from claimants for $6.5 billion talc settlement – BloombergInvesting.com
2 months Why Is Johnson & Johnson (JNJ) the Best Cosmetic Surgery and Aesthetics Stock To Buy Now?Insider Monkey
2 months Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From NowThe Motley Fool
2 months Forget Johnson & Johnson: Another Healthcare Giant Is a Much Better Bet for GrowthThe Motley Fool
2 months If You Invested $1000 In Johnson & Johnson Stock 20 Years Ago, How Much Would You Have Now?Yahoo Finance
2 months Could Johnson & Johnson’s Troubles With Talc Lawsuits Finally Be Coming to an End?Yahoo Finance
2 months Stocks making the biggest moves midday: Nvidia, Johnson & Johnson, Sweetgreen, GitLab and moreCNBC
2 months Johnson & Johnson Makes A Bullish Move On A Second-Quarter Beat — With CaveatsInvestor's Business Daily
2 months Johnson & Johnson (JNJ): Did this Dividend Stock Outperform During the Last Quarter?Insider Monkey
3 months Johnson & Johnson (JNJ): One of the Best Blue Chip Dividend Stocks Right Now According to Hedge Funds?Insider Monkey
3 months Johnson & Johnson: A Lot Of Moving Parts, But Perhaps Finally Lurching In The Right DirectionSeeking Alpha